Horizon Pharma Inc
(NASDAQ: HZNP)
+0.01
+0.42%
Horizon Pharma Inc, a small-cap growth company in the health care sector, is expected to underperform the market over the next six months with very high risk.
10 is the best possible rating.
Shares are under heavy accumulation by financial institutions. Positive for a small company like HZNP
ConThe price-to-sales multiple is significantly higher than the average for all stocks in the StockScouter universe. Negative for a small company like HZNP
The price-to-earnings multiple is a negative number. No effect
The StockScouter measure of relative price change and consistency is very low. Very negative
The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative
Earnings growth information is unavailable or inconsistent.
Analysts have issued conflicting earnings estimate revisions for HZNP. Neutral
Insider trading information is unavailable or inconsistent.
Shares are under heavy accumulation by financial institutions. Positive for a small company like HZNP
The price-to-earnings multiple is a negative number. No effect
The price-to-sales multiple is significantly higher than the average for all stocks in the StockScouter universe. Negative for a small company like HZNP
The ratio of HZNP's price-to-earnings multiple to its five-year growth rate is unavailable or inconsistent.
The StockScouter measure of relative price change and consistency is very low. Very negative
Previous day's closing price for HZNP was close to its 50-day moving average. Neutral
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 5/25/2013 6:51 AM ET
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
